{"nct_id":"NCT06758401","title":"This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-07-23","start_date_type":"ACTUAL","primary_completion_date":"2028-09-05","primary_completion_date_type":"ESTIMATED","completion_date":"2029-03-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}